Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc

NAS:SNDX (USA)  
$ 13.07 -0.24 (-1.8%) 11:08 PM EST
At Loss
P/B:
3.10
Enterprise V:
$ 710.94M
Volume:
2.73M
Avg Vol (2M):
2.28M
Trade In:
Volume:
2.73M
At Loss
Avg Vol (2M):
2.28M

Business Description

Description
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
Name Current Vs Industry Vs History
Cash-To-Debt 475.87
Equity-to-Asset 0.86
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.31
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 29.67
9-Day RSI 28.37
14-Day RSI 30.36
6-1 Month Momentum % -18.74
12-1 Month Momentum % -23.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.99
Quick Ratio 6.99
Cash Ratio 6.84
Days Sales Outstanding 77.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21
Shareholder Yield % 0.03

Financials (Next Earnings Date:2025-02-27 Est.)

SNDX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SNDX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Syndax Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 16
EPS (TTM) ($) -3.63
Beta 0.75
Volatility % 43.58
14-Day RSI 30.36
14-Day ATR ($) 0.816136
20-Day SMA ($) 14.944
12-1 Month Momentum % -23.16
52-Week Range ($) 12.75 - 25.34
Shares Outstanding (Mil) 85.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syndax Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Syndax Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Syndax Pharmaceuticals Inc Frequently Asked Questions

What is Syndax Pharmaceuticals Inc(SNDX)'s stock price today?
The current price of SNDX is $13.07. The 52 week high of SNDX is $25.34 and 52 week low is $12.75.
When is next earnings date of Syndax Pharmaceuticals Inc(SNDX)?
The next earnings date of Syndax Pharmaceuticals Inc(SNDX) is 2025-02-27 Est..
Does Syndax Pharmaceuticals Inc(SNDX) pay dividends? If so, how much?
Syndax Pharmaceuticals Inc(SNDX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1